S
Sirion Therapeutics
Innovative ophthalmic solutions enhancing eye health through advanced pharmaceutical therapies
About Sirion Therapeutics
Sirion Therapeutics is a pharmaceutical company specializing in the development and commercialization of innovative therapies for eye diseases. The company targets a broad range of clients, including healthcare providers, ophthalmologists, and patients suffering from various ocular conditions. Operating within the medical and pharmaceutical markets, Sirion Therapeutics employs a business model focused on research and development, followed by the commercialization of its proprietary treatments. Revenue is generated through the sale of these specialized pharmaceutical products. The company leverages its expertise in ophthalmology to address unmet medical needs, ensuring improved patient outcomes and eye health.
Source: Dealroom company dataKnowledge graph
News
Open roles
Sirion Therapeutics in the Tampa ecosystem
The Sirion Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
NovaQuest Capital Management
Aisling Capital
Advent International
Atlas Venture
Investor Growth Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sirion Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sirion Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
